Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AC Platelet aggregation inhibitors excl. heparin
B01AC25 Cangrelor
D03359 Cangrelor (USAN/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01294 Cangrelor
D03359 Cangrelor
DG01809 P2Y12 receptor antagonist
DG01294 Cangrelor
D03359 Cangrelor
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Purine / pyrimidine
P2RY12
D03359 Cangrelor (USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03359
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03359
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03359
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01294 Cangrelor
DG01809 P2Y12 receptor antagonist
DG01294 Cangrelor